Organic Chemistry TRIZ Cases

Tumor β-glucuronidase activates glucuronyl prodrugs to release anticancer agents selectively, minimizing side effects in healthy tissues.

Cationic ring-opening polymerization builds azide groups into hydrophilic copolymers, increasing reactive-site density without post-modification.

Small-molecule compounds bind the KIF18A ATPase active site to block activity, induce mitotic arrest, and promote apoptosis in cancer cells.

Electronically conductive, ion-sensitive polymers distinguish K+, Na+, and Zn2+ fluxes while enabling noninvasive, long-term biological monitoring.

Fused-ring aromatic amines improve hole mobility in organic EL layers, lowering driving voltage and extending lifetime at high temperature.

Formula (I) compounds activate HIV protease prematurely, triggering inflammatory death in infected cells to clear viral reservoirs.

Pyridazine and triazine spirocyclic amines inhibit menin/MLL while addressing metabolic stability and oral bioavailability.

Replacing hazardous diisocyanates, this one-pot route uses carbonyldiimidazole and propargylamine for REACH-compliant energetic-material binders.

Basic alumina combines hydrogen peroxide and fatty acids without organic solvent to limit diol formation and improve epoxide conversion and selectivity.

Specific heterocyclic compounds in OLED layers improve luminance and response speed while reducing driving voltage for full-color images.

L-Tartaric acid resolves racemic 2-amino-4-halobutyric acid derivatives through salt formation, crystallization, and filtration.

Fluorinated aromatic onium cations improve lithography sensitivity, while tailored anion basicity helps limit storage drift in resist performance.

Strong AR antagonism with minimal agonism enables diarylhydantoin compounds to inhibit hormone-refractory prostate cancer growth.

Mutant- and wild-type PKR activators address severe PKD hemolytic anemia by restoring ATP production and extending red blood cell lifetime.

EP300 degraders recruit an E3 ubiquitin ligase and the proteasome to address weak tumor regression and poor CBP selectivity.

Sulfonyl cyclic derivatives address high-concentration TRPML activator limits through potent channel activation and improved oral bioavailability.

Pre-isomerization converts alpha olefins before hydroformylation, shifting production from linear toward branched aldehydes and alcohols.

Carbazole, triphenylene, and boron-nitrogen host compounds balance charge transport to improve OLED voltage, efficiency, and lifetime.

Combining Montelukast with a β2 agonist in one salt addresses repeated dosing, receptor desensitization, and reduced airway efficacy.

Limited metabolic stability constrains RIP1 therapies; piperazine cyclic ureas inhibit necroptosis and ferroptosis with high stability.

Di-thioester cationic lipids form liposomes for effective in vivo mRNA delivery and high protein production while maintaining a favorable toxicity profile.

Substituted arylsulfonamides modulate cereblon to selectively degrade GSPT1 while limiting degradation of IKZF1.

Novel degraders use cereblon-binding ligands, linkers, and target ligands to address limited specificity and compound stability.

Low fill factor and open-circuit voltage limit large-area OPVs; DTP-4X tunes energy levels and absorption to improve both.

An intermediary message system turns website triggers into product-centered cards delivered asynchronously, even outside site interaction.

Bifunctional compounds link a cereblon-binding moiety to a target-protein ligand, enabling selective ubiquitination and degradation across protein classes.

Actinium-225 chelation challenges are addressed with macrocyclic structures that support stable, high-specific-activity radioimmunoconjugates.

Low-solubility, aggregation-prone MTP and Apo-B inhibitors are micronized for homogeneous dispersion, stable suspension, and consistent release.

Structural changes to amido cyclohexane derivatives preserve LPA1 potency while improving BSEP profile and permeability for oral fibrosis treatment.

Proteasome-targeting aminonaphthoquinone compounds address limited fibrosis-treatment efficacy while reducing cytotoxicity and genotoxicity.

Pd or Pt-catalyzed hydrogenation uses formaldehyde to produce N-methylated piperidines with high yield and less waste.

Moderate-temperature catalyst control replaces extreme heat and vacuum in lactide depolymerization, reducing racemization while preserving reaction efficiency.

Lower-temperature palladium-catalyzed reactions simplify synthesis while supporting heat-resistant, low-voltage organic EL devices with high color purity.

Cyclopropyl derivatives intensify fragrance notes while improving stability, solubility, and biodegradability at lower dosage.

Naphthofuran-based heterocyclic compounds form mixed OLED hosts that balance carriers, improve exciton use, and extend device life.

Conventional OLED materials can limit carrier mobility and exciton use; a substituted dibenzofuranyl host broadens recombination and supports efficient emission.

Chlorine gas and catalytic amide bases produce chlorobenzaldehyde oximes while limiting exothermic behavior, solvent hazards, and waste.

pH-responsive lipid chemistry supports endosomal escape while reducing accumulation-related toxicity in nucleic acid nanoparticles.

Replacing sodium triacetoxyborohydride with formic acid completes the cariprazine reduction in under 1 hour with less hazardous waste.

See how metal alkoxide bases address low yield and difficult isolation in 4-substituted 2-oxazolidinone production.

Rh(I) cycloisomerization builds tetracyclic coumarin scaffolds, while reduction produces shelf-stable axially chiral cannabinoids.

E3 ligase recruitment enables bifunctional STAT6 degraders to remove the protein through the ubiquitin-proteasome pathway.

Targeted compounds block eIF4E activity at cap-binding or eIF4G interface regions, addressing limited options for cancer therapy.

Specific donor–acceptor compounds tune molecular structure for stronger, more efficient electroluminescence in organic light-emitting devices.

TRPV1 agonists open a temporary membrane pathway for charged anesthetics, extending local anesthesia while limiting neurotoxicity.

Selective OCT1, OCT2, OCT3, PMAT, and MATE1 targeting addresses metformin’s limited transporter selectivity while reducing renal elimination.

The light-emitting layer combines fluorene, spirofluorene, or biphenyl structures with a carbazole-containing substituent to support durable phosphorescent emission.

Paired palladium catalysts distinguish β- and γ-methylene C–H bonds to form useful γ- and δ-lactones from dicarboxylic acids.

Specific host-compound combinations and tailored substituents address OLED trade-offs among driving voltage, luminous efficiency, and lifetime.

TEMPO-based tags combine fluorescence quantitation with diagnostic free-radical MS fragmentation, reducing reagent use in glycan analysis.

Lipase-mediated transesterification produces acetoacetate derivatives without hazardous diketene or toxic organic solvents.

Replacing zinc dialkyldithiophosphates with diaromatic amine additives eliminates phosphorus pollution while maintaining oxidation stability.

Ring-modified proline short peptide compounds inhibit the SARS-CoV-2 3CL protease, resolving the lack of targeted therapy without cytotoxicity.

Pre-reacted aqueous solutions of substituted hydrocarbons and amines eliminate organic solvent use and purification steps during molecular sieve synthesis.

N-aryl substituents and sulfonic groups in cyanine dyes prevent aqueous aggregation, enhancing fluorescence stability.

A furanone compound imparts sweet tonka acacia and woody notes to compositions.

Blending cyclic carbonates with MDEA resolves low-pressure performance drops in acid gas scrubbing while reducing regeneration energy.

An amine-based compound enhances hole transportability in organic light-emitting devices.

Mitoriboscins inhibit mitochondrial biogenesis via ribosome targeting, reducing tumor recurrence and antibiotic resistance.

Pyrimidine derivatives with bulky substituents achieve high solubility and stability, resolving the trade-off between charge mobility and wet film formation.

Engineered squalene-hopene cyclase replaces harsh acid catalysis, eliminating toxic waste while maintaining ambient temperature operation.

Acid-catalyzed borrerine dimerization reduces synthesis steps by over 80%, enabling cost-effective production of antimalarial therapeutics.

Crystalline porous polymer catalysts enable high-yield lactide synthesis through molecular confinement effects.

Segmented PROTAC molecules recruit E3 ligases to degrade 3CL protease, expanding pharmacodynamic pathways beyond simple inhibition.

Flexible linkers in a rosamine derivative library prevent fluorescence quenching during protein labeling, enabling sensitive macromolecule detection.

Sulfone compounds in the electrolytic solution prevent decomposition reactions, enhancing cycle and storage characteristics under high temperatures.

Quaternary ammonium isatoic anhydrides facilitate aqueous coupling, reducing side products and reagent costs.

Branched isobutylene elastomers broaden molecular weight distribution to enhance melt flow and green strength.

Salt and crystalline forms of the nucleoside analogue improve bioavailability and stability while maintaining manufacturability.

Carboxylic diarythiazepineamines merge mu and delta opioid receptor activation to resolve the contradiction between analgesic efficacy and addiction liability.

Converting the ester to a potassium salt before acidification resolves filtration difficulties and browning, improving yield.

Heating aqueous salt solutions enables polyimide production while avoiding high energy expenditure for hydrothermal conditions.

Tetracyclic pyrazinoindoles stabilize mitochondria and inhibit apoptotic cell death to address limited treatment effectiveness in mitochondrial diseases.

Bulky hydrocarbyl substituents lower nitrogen levels, resolving the trade-off between oxidation protection and piston deposit formation.

Optimized oral dosing of Compound A maintains therapeutic efficacy while minimizing off-target effects in FOP treatment.

WO3/SiO2/Fe3O4 catalyst enables magnetic recovery, reducing waste and cost in quinolone drug synthesis.

Carbazole compounds with cyano groups reduce driving voltage and extend device lifespan by balancing electron-hole transport.

Replacing amine reagents with metal azides in ether solvents prevents genotoxic nitrosamine impurity formation during sartan synthesis.

Selective S1P5 agonists reduce ceramide-mediated cell death and neuroinflammation without engaging cardiovascular or immunomodulatory receptors.

Non-aqueous synthesis of bendamustine hydrochloride uses lithium hydrolysis and inert atmosphere control to prevent degradation impurities.

Benzimidazole emitters enable thermally activated delayed fluorescence, exceeding the 25% spin statistics limit for internal quantum efficiency.

Specific cyclic sulfate compounds suppress open circuit voltage decay during storage while maintaining high capacity retention.

Formula I compounds bind eIF4E with high selectivity, resolving specificity trade-offs in cancer therapy.

Pegylated lipids form lipid nanoparticles that protect nucleic acids from nuclease digestion in plasma.

Imidazopyridine compounds inhibit PDGFR and FLT3 to address inadequate targeting of class 3 and 5 receptor tyrosine kinases.

Combining N-type and P-type host materials balances electrons and holes, lowering driving voltage while maintaining high emission efficiency.

Modifying quinic acid reduces cytotoxicity while maintaining stability for treating autoimmune diseases.

Computational model estimates catalyst selectivity to determine optimal chloride moderator levels, resolving gas phase measurement precision constraints.

Deuterium substitution strengthens C-D bonds to increase device lifetime while maintaining air tolerance and processing flexibility.

Pyrolyzing anhydrous alkaline-earth salts yields high-purity cyclic diesters while eliminating racemization and reducing energy consumption.

An imide-based photocurable adhesive maintains adhesion during 300°C processing while allowing clean separation without residue upon cooling.

Branched alkyl bis-urea compounds lower viscosity below 15 cps at 140°C, resolving the trade-off between adhesion and thermal stability in phase-change inks.

A coaxial reactor design merges primary and secondary chambers into a single vertical vessel to consolidate melamine synthesis functions.

Ion exchange of tiotropium bicarbonate with varied acids yields high-purity salts, resolving synthesis complexity and universality constraints.

Methylmorpholine-N-oxide converts hydrogen sulfide to elemental sulfur without violent exothermic reactions or ammonia generation.

Bifunctional compounds recruit endogenous E3 ubiquitin ligases to specific target proteins for targeted degradation.

Active energy ray-curable epoxy organopolysiloxane resin composition cures rapidly to form high-transmittance optical waveguides.